On Wed, 13 Nov 2002 12:11:37 EST, [email protected] wrote: >snip > >The in-vitro lab results conclusively demonstrate that a high quality >isolated colloidal silver product is remarkably effective in concentrations >of both 15 PPM and 30 PPM against Staph Aureus. A greater concentration >demonstrated faster action, however, the results in the first four minutes >dropped population counts to nearly non-existant levels with both >formulations. > >end snip >
When in-vitro results (as above) are stated, how does that transfer to in-vivo situations. Does the CS in the bloodstream need to reach similar values to expect similar results? Regards, George Martin -- The silver-list is a moderated forum for discussion of colloidal silver. Instructions for unsubscribing may be found at: http://silverlist.org To post, address your message to: [email protected] Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <[email protected]>
